Direct Single-Dose Drug-Provocation Test Is Safe for Delabelling Penicillin Low-Risk Reactions in Adults

dc.centroFacultad de Medicinaes_ES
dc.contributor.authorLabella, Marina
dc.contributor.authorRodriguez de Guzmán, Julia
dc.contributor.authorDiez-Echave, Patricia
dc.contributor.authorSalas, María
dc.contributor.authorFernández-Santamaría, Rubén
dc.contributor.authorMayorga Mayorga, Cristobalina
dc.contributor.authorDoña, Inmaculada
dc.contributor.authorTorres-Jaén, María Josefa
dc.date.accessioned2025-05-27T12:30:58Z
dc.date.available2025-05-27T12:30:58Z
dc.date.issued2025
dc.departamentoMedicina y Dermatologíaes_ES
dc.description.abstractBackground: Penicillins (PENs) are the most frequent drug-allergic reactions trigger. However, diagnostic work-up is complex and time-consuming: it requires skin testing (ST) and drug-provocation test (DPT), needing faster delabelling strategies. Although direct DPT without previous STs has shown to be safe, most of the studies are performed in children or in North American, Asian, or Oceanian adults, with few studies in the European adult population. We explored its safety in European adult patients with low-risk PEN allergy history and, additionally, analysed ST role and T-cell involvement by lymphocyte trans- formation test (LTT). Methods: We prospectively evaluated > 16 years of PEN-allergic labelled patients referred to Málaga Regional University Hospital during 2023. They reported non-immediate reactions without alarm signs and unknown reactions. Direct-single-dose DPT was performed in all patients. If positive, ST and LTT were carried out after reaction resolution. Results: We included 269 patients with the culprits being an unidentified PEN (36%), amoxicillin (AX) (32%), and AX-clavulanic acid (AX- CLV) (31%); and the symptoms maculopapular exanthema (MPE) (34%) and unknown reaction during childhood (23%). Only 16 (5.9%) had positive DPT, being 56% for AX and 44% for AX- CLV, 81% developing MPE, none severe. Most DPT-reacting patients reported cutaneous non-immediate reactions in the index reaction, and only one had an unknown childhood reaction. The mean day interval between drug administration and symptom development was lower (p = 0.002) in positive DPT than in the index reaction (2 vs 5 days). Moreover, ST was positive in only 19% and LTTs in 86.7% of positive DPT patients. Conclusions: Direct-single-dose DPT is safe for delabelling PEN allergy in non-immediate reactions without alarm signs and unknown reactions. ST had a poor diagnostic value and LTT had a high one, confirming a T-cell involvement.es_ES
dc.description.sponsorshipThis study has been supported by the Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofounded by European Regional Development Fund) (PI21/00329); and through its programme of Redes de Investigacion Cooperativa Orientadas al Resultado en Salud (RICORS): Enfermedades Inflamatorias (RD21/0002/0008). ML holds a contract from “Juan Rodes” program (JR23/0039) from the Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness [grants co-funded by European Social Fund (ESF)]. PDE holds a Sara Borrell research contract by Institute of Health “Carlos III” (CD22/00112). CM holds a “Nicolas Monardes” research contract by Andalusian Regional Ministry Health (RC- 0004-2021). Funding for open access charge: Universidad de Málaga/CBUA.es_ES
dc.identifier.citationLabella, M., Rodriguez de Guzmán, J., Diez-Echave, P., Salas, M., Fernández-Santamaría, R., Mayorga, C., Doña, I. and Torres, M.J. (2025), Direct Single-Dose Drug-Provocation Test Is Safe for Delabelling Penicillin Low-Risk Reactions in Adults. Allergy. https://doi.org/10.1111/all.16567es_ES
dc.identifier.doi10.1111/all.16567
dc.identifier.urihttps://hdl.handle.net/10630/38756
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectDiagnóstico de laboratorioes_ES
dc.subjectAlergia a los medicamentoses_ES
dc.subjectPenicilinaes_ES
dc.subject.otherBetalactames_ES
dc.subject.otherDelabellinges_ES
dc.subject.otherDrug-provocation testes_ES
dc.subject.otherHypersensitivity reactiones_ES
dc.subject.otherLymphocyte transformation testes_ES
dc.subject.otherPenicillines_ES
dc.subject.otherSingle dosees_ES
dc.titleDirect Single-Dose Drug-Provocation Test Is Safe for Delabelling Penicillin Low-Risk Reactions in Adultses_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationabcd4607-b47d-4018-86ad-3b5f76cbee1e
relation.isAuthorOfPublication.latestForDiscoveryabcd4607-b47d-4018-86ad-3b5f76cbee1e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Allergy - 2025 - Labella - Direct Single‐Dose Drug‐Provocation Test Is Safe for Delabelling Penicillin Low‐Risk Reactions.pdf
Size:
341.48 KB
Format:
Adobe Portable Document Format
Description:

Collections